Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Local recurrence after cystectomy alone for bladder carcinoma.

K M Greven1, J A Spera, L J Solin

  • 1Department of Radiology, Bowman Gray School of Medicine, Winston-Salem, NC 27157-1088.

Cancer
|June 1, 1992
PubMed
Summary

For bladder carcinoma patients undergoing cystectomy alone, pelvic recurrences occurred in 18% within 5 years. Pathologic stage significantly predicted local recurrence risk, highlighting the need for better failure pattern documentation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Head and neck radiotherapy quality assurance conference for dedicated review of delineated targets and organs at risk: results of a prospective study.

Journal of radiotherapy in practice·2024
Same author

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.

Breast cancer research and treatment·2018
Same author

Retrospective analysis of the impact of HPV status and smoking on mucositis in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemotherapy and radiotherapy.

Oral oncology·2014
Same author

Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.

Journal of surgical oncology·2007
Same author

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004
Same author

The Consensus Conference on the Treatment of in situ Ductal Carcinoma of the Breast, 22-25 April 1999.

Breast (Edinburgh, Scotland)·2004

Area of Science:

  • Urology
  • Oncology
  • Surgical Oncology

Background:

  • The role of preoperative irradiation in bladder carcinoma treatment remains debated.
  • Patterns of local failure after cystectomy alone for bladder cancer are not well-documented.
  • Understanding failure patterns is crucial for optimizing multimodal treatment strategies.

Purpose of the Study:

  • To retrospectively analyze local failure patterns in patients treated with cystectomy without adjuvant therapy.
  • To identify predictors of local recurrence after radical cystectomy.
  • To establish a basis for evaluating combined treatment modalities.

Main Methods:

  • Retrospective analysis of 83 patients (67 men, 16 women) who underwent cystectomy without adjuvant therapy.
  • Disease staging assessed preoperatively (clinical) and postoperatively (pathologic).

Related Experiment Videos

  • Follow-up duration ranged from 0 to 167 months.

    • Main Results:

    • Thirteen patients (18% 5-year actuarial rate) experienced pelvic recurrences.
    • Pathologic stage was the sole significant predictor of local recurrence.
    • Local recurrence rates varied from 6% for pT2 to 51% for pT3b tumors.
    • Median time to local recurrence was 9 months.

    Conclusions:

    • Pathologic stage is a critical factor in predicting local recurrence after cystectomy for bladder carcinoma.
    • Detailed documentation of failure patterns is essential for assessing the efficacy of combined treatments.
    • Findings support further investigation into multimodal approaches including preoperative radiation therapy.